Immunotherapy with Mycobacterium vaccae combined with second line chemotherapy in drug-resistant abdominal tuberculosis.
Department of Thoracic Medicine, Gloucestershire Royal NHS Trust, U.K.
J G
JG
Prior
A A
AA
Khan
K A
KA
Cartwright
P A
PA
Jenkins
J L
JL
Stanford
D000328:Adult; D000995:Antitubercular Agents / Q000627:therapeutic use; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D007167:Immunotherapy; D009161:Mycobacterium / Q000276:immunology*; D014395:Peritonitis, Tuberculous / Q000628:therapy*; D013045:Species Specificity; D018088:Tuberculosis, Multidrug-Resistant / Q000628:therapy*
D000995:Antitubercular Agents